VXRT LONG term investment

Vaxart (NASDAQ:VXRT) The company is working on a vaccine for the novel coronavirus that works via tablets instead of injection. If Vaxart reports positive results from this clinical trial, investors will likely see shares of VXRT stock soar higher. Be first to capitalize on, in my opinion the best alternative for Covid 19, a oral pill solution

Good luck